User:Tobias1984/Testcase table

Tobias1984/Testcase table
Clinical data
Trade names	Linospan, Zyvox, Zyvoxam, Zyvoxid
AHFS/Drugs.com	Monograph
MedlinePlus	a602004
License data	US FDA: Linezolid;
Pregnancy; category	C (Au), C (U.S.);
Routes of; administration	Intravenous infusion, oral
ATC code	J01XX08 (WHO) ;
Legal status
Legal status	S4 (Au), POM (UK), ℞-only (U.S.);
Pharmacokinetic data
Bioavailability	~100% (oral)
Protein binding	Low (31%)
Metabolism	Hepatic (50–70%, CYP not involved)
Onset of action	1 hr
Elimination half-life	4.2–5.4 hours (shorter in children)
Excretion	Nonrenal, renal, and fecal
Identifiers
	IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide;
CAS Number	165800-03-3 ;
PubChem CID	441401;
DrugBank	DB00601;
ChemSpider	390139 ;
UNII	ISQ9I6J12J;
KEGG	D00947 ;
ChEMBL	ChEMBL126 ;
NIAID ChemDB	070944;
PDB ligand	ZLD (PDBe, RCSB PDB);
Chemical and physical data
Formula	C16H20FN3O4
Molar mass	337.346 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3;
	InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 ; Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N ;
	(what is this?) (verify)